These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 14687958)

  • 1. Cost-effectiveness analysis of addiction treatment: paradoxes of multiple outcomes.
    Sindelar JL; Jofre-Bonet M; French MT; McLellan AT
    Drug Alcohol Depend; 2004 Jan; 73(1):41-50. PubMed ID: 14687958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Out of touch or on the money: Do the clinical objectives of addiction treatment coincide with economic evaluation results?
    Dismuke CE; French MT; Salomé HJ; Foss MA; Scott CK; Dennis ML
    J Subst Abuse Treat; 2004 Oct; 27(3):253-63. PubMed ID: 15501378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit-cost analysis of addiction treatment: methodological guidelines and empirical application using the DATCAP and ASI.
    French MT; Salomé HJ; Sindelar JL; McLellan AT
    Health Serv Res; 2002 Apr; 37(2):433-55. PubMed ID: 12036002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using the DATCAP and ASI to estimate the costs and benefits of residential addiction treatment in the State of Washington.
    French MT; Salomé HJ; Carney M
    Soc Sci Med; 2002 Dec; 55(12):2267-82. PubMed ID: 12409139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost estimation when time and resources are limited: the Brief DATCAP.
    French MT; Roebuck MC; McLellan AT
    J Subst Abuse Treat; 2004 Oct; 27(3):187-93. PubMed ID: 15501371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs and effectiveness of substance abuse treatments for homeless persons.
    Schumacher JE; Mennemeyer ST; Milby JB; Wallace D; Nolan K
    J Ment Health Policy Econ; 2002 Mar; 5(1):33-42. PubMed ID: 12529568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creating an aggregate outcome index: cost-effectiveness analysis of substance abuse treatment.
    Jofre-Bonet M; Sindelar JL
    J Behav Health Serv Res; 2004; 31(3):229-41. PubMed ID: 15263863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of public sector substance abuse treatment: comparison of a managed care approach to a traditional public sector system.
    Beattie MC; Hu TW; Li R; Bond JC
    J Behav Health Serv Res; 2005; 32(4):409-29. PubMed ID: 16215450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidimensional impact of treatment for substance abuse.
    Hoffmann NG; Harrison PA; Belille CA
    Adv Alcohol Subst Abuse; 1984; 3(3):83-94. PubMed ID: 6496235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of full vs. partial continuum of care in the treatment of publicly funded substance abusers in Washington State.
    McKay JR; Donovan DM; McLellan T; Krupski A; Hansten M; Stark KD; Geary K; Cecere J
    Am J Drug Alcohol Abuse; 2002; 28(2):307-38. PubMed ID: 12014818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Employment and addiction.
    Bickel WK
    Hosp Community Psychiatry; 1994 Feb; 45(2):178. PubMed ID: 8168803
    [No Abstract]   [Full Text] [Related]  

  • 12. Supplemental social services improve outcomes in public addiction treatment.
    McLellan AT; Hagan TA; Levine M; Gould F; Meyers K; Bencivengo M; Durell J
    Addiction; 1998 Oct; 93(10):1489-99. PubMed ID: 9926553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the economic cost of substance abuse treatment.
    French MT; McGeary KA
    Health Econ; 1997; 6(5):539-44. PubMed ID: 9353658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relative contribution of outcome domains in the total economic benefit of addiction interventions: a review of first findings.
    McCollister KE; French MT
    Addiction; 2003 Dec; 98(12):1647-59. PubMed ID: 14651494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using cost and financing instruments for economic evaluation of substance abuse treatment services.
    Salomé HJ; French MT
    Recent Dev Alcohol; 2001; 15():253-69. PubMed ID: 11449745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the client costs of addiction treatment: first findings from the client drug abuse treatment cost analysis program (Client DATCAP).
    Salomé HJ; French MT; Miller M; McLellan AT
    Drug Alcohol Depend; 2003 Aug; 71(2):195-206. PubMed ID: 12927658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can the Treatment Services Review be used to estimate the costs of addiction and ancillary services?
    French MT; Roebuck MC; McLellan AT; Sindelar JL
    J Subst Abuse; 2000; 12(4):341-61. PubMed ID: 11452838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation of drug abuse treatment programs: methodology and findings.
    French MT
    Am J Drug Alcohol Abuse; 1995 Feb; 21(1):111-35. PubMed ID: 7762538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditional outpatient regimens.
    Weisner C; Mertens J; Parthasarathy S; Moore C; Hunkeler EM; Hu T; Selby JV
    Health Serv Res; 2000 Oct; 35(4):791-812. PubMed ID: 11055449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Client outcomes from rural substance abuse treatment.
    Hiller ML; Leukefeld CG; Garrity TF; Godlaski T; Schoeneberger M; Townsend M; Hascal K
    J Psychoactive Drugs; 2007 Mar; 39(1):59-68. PubMed ID: 17523586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.